Your browser doesn't support javascript.
loading
Short-term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis.
Macaluso, Claudio; Boccabella, Cristina; Kokosi, Maria; Sivarasan, Nishanth; Kouranos, Vasilis; George, Peter M; Margaritopoulos, George; Molyneaux, Philip L; Chua, Felix; Maher, Toby M; Jenkins, Gisli R; Nicholson, Andrew G; Desai, Sujal R; Devaraj, Anand; Wells, Athol U; Renzoni, Elisabetta A; Stock, Carmel J W.
Afiliación
  • Macaluso C; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Boccabella C; Department of Pneumology, INRCA/IRCCS, "L.Mandic" Hospital Merate (LC), Merate, Italy.
  • Kokosi M; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sivarasan N; Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, University of the Sacred Heart, Rome, Italy.
  • Kouranos V; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • George PM; Department of Radiology, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Margaritopoulos G; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Molyneaux PL; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Chua F; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
  • Maher TM; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Jenkins GR; ILD Unit, London North West University Hospital Healthcare Trust, London, UK.
  • Nicholson AG; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Desai SR; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Devaraj A; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
  • Wells AU; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Stock CJW; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
Respirology ; 27(3): 202-208, 2022 03.
Article en En | MEDLINE | ID: mdl-35023231
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Alveolitis Alérgica Extrínseca / Linfocitosis Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respirology Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Alveolitis Alérgica Extrínseca / Linfocitosis Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respirology Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido